| 13.74 Data as of May 22 |  +0.23 / +1.70%Today’s Change | 10.15 Today|||52-Week Range 17.15 | +22.13% Year-to-Date |
| Previous close | 13.51 |
| Today’s open | 13.49 |
| Day’s range | -- - -- |
| Volume | 622,191 |
| Average volume (3 months) | 307,303 |
| Market cap | $807.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +33.33% |
| Earnings growth (this year) | +0.96% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +11.45% |
| P/E ratio | NM |
| Price/Sales | 2.69 |
| Price/Book | 4.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXELExelixis Inc | -0.03 | -0.65% |
| BRLIBio-Reference Labora... | +0.44 | +1.44% |
| KERXKeryx Biopharmaceuti... | -0.17 | -2.11% |
| AMRNAmarin Corporation P... | -0.09 | -1.29% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $242.1M |
| Annual profit (last year) | -$15.2M |
| Net profit margin | -6.26% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Jeffrey H. Burbank |
Chief Financial Officer, Treasurer & Senior VP Robert S. Brown, MBA, CPA |
Corporate headquarters Lawrence, Massachusetts |
.
